TY  - JOUR
AU  - Del Alcázar, Elena
AU  - López-Ferrer, Anna
AU  - Martínez-Doménech, Álvaro
AU  - Ruiz-Villaverde, Ricardo
AU  - Llamas-Velasco, Mª Del Mar
AU  - Rocamora, Vicenç
AU  - Julià, Marc
AU  - Notario, Jaime
AU  - Fernández-Freire, Lourdes Rodríguez
AU  - Sahuquillo-Torralba, Antonio
AU  - Vidal, David
AU  - Rivera, Raquel
AU  - Carretero, Gregorio
AU  - Mateu, Almudena
AU  - de la Cueva, Pablo
AU  - Carrascosa, José Manuel
PY  - 2022
DO  - 10.1111/dth.15231
UR  - https://hdl.handle.net/10668/26154
T2  - Dermatologic therapy
AB  - Data on the effectiveness and safety of a drug in real-world clinical practice complement the evidence from clinical trials, which are carried out in a different setting. Little has been published on the effectiveness and safety of guselkumab in the...
LA  - en
KW  - guselkumab
KW  - psoriasis
KW  - real-world
KW  - Adult
KW  - Antibodies, Monoclonal, Humanized
KW  - Humans
KW  - Psoriasis
KW  - Retrospective Studies
KW  - Severity of Illness Index
KW  - Treatment Outcome
TI  - Effectiveness and safety of guselkumab for the treatment of psoriasis in real-world settings at 24 weeks: A retrospective, observational, multicentre study by the Spanish Psoriasis Group.
TY  - research article
VL  - 35
ER  -